RPRX earnings
Royalty Pharma (RPRX) next earnings date and estimates, and its past reports: EPS against estimates, the surprise and revenue.
RPRX earnings history
| Quarter | Reported | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|---|
| Q2 2026 | Aug 5, 2026 | 1.32 | 1.27 | 3.94% | $674.14M |
| Q1 2026 | May 6, 2026 | 1.30 | 1.21 | 7.44% | $630.58M |
| Q4 2025 | Feb 11, 2026 | 1.46 | 1.29 | 13.18% | $621.99M |
| Q3 2025 | Nov 5, 2025 | 1.17 | 0.99 | 17.71% | $609.29M |
| Q2 2025 | Aug 6, 2025 | 1.14 | 1.03 | 10.68% | $578.66M |
| Q1 2025 | May 8, 2025 | 1.06 | 0.95 | 11.23% | $568.25M |
| Q4 2024 | Feb 11, 2025 | 1.15 | 0.99 | 16.16% | $593.64M |
| Q3 2024 | Nov 6, 2024 | 1.04 | 0.93 | 12.07% | $564.69M |
| Q2 2024 | Aug 8, 2024 | 0.96 | 0.96 | -0.52% | $537.27M |
| Q1 2024 | May 9, 2024 | 0.98 | 0.99 | -0.71% | $567.98M |
| Q4 2023 | Feb 15, 2024 | 1.15 | 1.01 | 13.86% | $596.07M |
| Q3 2023 | Nov 8, 2023 | 0.79 | 0.81 | -2.47% | $536.31M |
| Aug 8, 2023 | 0.85 | 0.83 | 2.41% | – | |
| May 9, 2023 | 1.60 | 1.32 | 21.21% | – | |
| Feb 15, 2023 | 1.56 | 1.56 | 0.00% | – | |
| Nov 8, 2022 | 0.73 | 0.71 | 2.82% | – | |
| Aug 4, 2022 | 0.79 | 0.78 | 1.28% | – | |
| May 5, 2022 | 0.61 | 0.72 | -15.28% | – | |
| Feb 15, 2022 | 0.80 | 0.79 | 1.27% | – | |
| Nov 10, 2021 | 0.73 | 0.69 | 5.80% | – |
- RPRX reports next on Nov 4, 2026, with EPS of 1.21 expected.
- RPRX beat EPS estimates in 19 of its last 25 reports.
Updated 2026-11-03 00:49 UTC